Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Adenocarcinoma"" wg kryterium: Temat


Starter badań:

Tytuł:
Clinicopathological characteristics and survival outcomes for patients with mucinous colorectal cancer liver metastases undergoing hepatic resection: A systematic review and meta-analysis.
Autorzy:
Reynolds IS; Department of Surgery, St Michael's Hospital, Co Dublin, Ireland; Department of Hepatobiliary and Liver Transplant Surgery, St Vincent's University Hospital, Dublin 4, Ireland. Electronic address: .
Cromwell PM; Department of Hepatobiliary and Liver Transplant Surgery, St Vincent's University Hospital, Dublin 4, Ireland.
Hoti E; Department of Surgery, St Michael's Hospital, Co Dublin, Ireland; Department of Hepatobiliary and Liver Transplant Surgery, St Vincent's University Hospital, Dublin 4, Ireland.
Pokaż więcej
Źródło:
American journal of surgery [Am J Surg] 2021 Sep; Vol. 222 (3), pp. 529-535. Date of Electronic Publication: 2021 Mar 03.
Typ publikacji:
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:
Adenocarcinoma, Mucinous*/mortality
Adenocarcinoma, Mucinous*/pathology
Adenocarcinoma, Mucinous*/secondary
Adenocarcinoma, Mucinous*/surgery
Colonic Neoplasms*/mortality
Colonic Neoplasms*/pathology
Colonic Neoplasms*/secondary
Colonic Neoplasms*/surgery
Hepatectomy*
Rectal Neoplasms*/mortality
Rectal Neoplasms*/pathology
Rectal Neoplasms*/secondary
Rectal Neoplasms*/surgery
Liver Neoplasms/*mortality
Adenocarcinoma/mortality ; Adenocarcinoma/pathology ; Adenocarcinoma/secondary ; Adenocarcinoma/surgery ; Age Factors ; Colorectal Neoplasms/mortality ; Colorectal Neoplasms/pathology ; Databases, Factual ; Female ; Humans ; Kaplan-Meier Estimate ; Liver Neoplasms/pathology ; Liver Neoplasms/secondary ; Liver Neoplasms/surgery ; Male ; Sex Factors
Czasopismo naukowe
Tytuł:
Neoadjuvant chemotherapy improves survival in patients with oesophageal mucinous adenocarcinoma: Post-hoc analysis of the UK MRC OE02 and OE05 trials.
Autorzy:
Liu DHW; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands; Institute of Clinical Pathology and Molecular Pathology, Kepler University Hospital and Johannes Kepler University, Linz, Austria.
Šefčovičová N; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands.
Emmerson J; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
Spaans LN; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands; Department of Surgery, Maxima Medical Centre, Eindhoven/Veldhoven, the Netherlands.
Saito Y; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands; Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan.
Hutchins G; Division of Pathology and Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
Nankivell MG; Medical Research Council Clinical Trials Unit at University College London, London, UK.
Langley RE; Medical Research Council Clinical Trials Unit at University College London, London, UK.
Allum W; Department of Oncology and Department of Surgery, Royal Marsden NHS Foundation Trust, London, UK.
Cunningham D; Department of Medicine, Royal Marsden Hospital, Sutton, Surrey, UK.
Langer R; Institute of Clinical Pathology and Molecular Pathology, Kepler University Hospital and Johannes Kepler University, Linz, Austria.
Grabsch HI; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands; Division of Pathology and Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK. Electronic address: .
Pokaż więcej
Źródło:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Jul; Vol. 170, pp. 140-148. Date of Electronic Publication: 2022 May 27.
Typ publikacji:
Clinical Trial, Phase III; Journal Article
MeSH Terms:
Adenocarcinoma*/pathology
Adenocarcinoma, Mucinous*/pathology
Esophageal Neoplasms*/pathology
Humans ; Mucins/therapeutic use ; Neoadjuvant Therapy ; Prognosis ; United Kingdom
SCR Disease Name:
Adenocarcinoma Of Esophagus
Czasopismo naukowe
Tytuł:
MicroRNA-1-3p affects lung adenocarcinoma progression through E2F8 and regulating NF-кB pathway.
Autorzy:
Lin Q; Cardiothoracic Surgery, Puyang Oilfield General Hospital, China. Electronic address: .
Pokaż więcej
Źródło:
Cytokine [Cytokine] 2022 Aug; Vol. 156, pp. 155922. Date of Electronic Publication: 2022 Jun 01.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*/genetics
Liver Neoplasms*
Lung Neoplasms*/pathology
MicroRNAs*/genetics
MicroRNAs*/metabolism
Cell Line, Tumor ; Cell Movement/genetics ; Cell Proliferation/genetics ; Humans ; NF-kappa B/genetics ; Repressor Proteins
Czasopismo naukowe
Tytuł:
Functional characterization and clinical significance of super-enhancers in lung adenocarcinoma.
Autorzy:
Jiang X; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Qin N; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
Hua T; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Wei X; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Li Y; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Chen C; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Gong L; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Liu S; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Wang C; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.; Department of Bioinformatics, School of Biomedical Engineering and Informatics, Nanjing Medical University, Nanjing, China.
Yin R; Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Department of Thoracic Surgery, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
Jiang Y; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
Dai J; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
Xu L; Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Department of Thoracic Surgery, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
Shen H; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.; Research Units of Cohort Study on Cardiovascular Diseases and Cancers, Chinese Academy of Medical Sciences, Beijing, China.
Ma H; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.; Research Units of Cohort Study on Cardiovascular Diseases and Cancers, Chinese Academy of Medical Sciences, Beijing, China.
Pokaż więcej
Źródło:
Molecular carcinogenesis [Mol Carcinog] 2022 Aug; Vol. 61 (8), pp. 776-786. Date of Electronic Publication: 2022 May 21.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*/drug therapy
Adenocarcinoma*/genetics
Adenocarcinoma*/metabolism
Adenocarcinoma of Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/metabolism
Cohort Studies ; Gene Expression Regulation, Neoplastic ; Humans ; Transcription Factor AP-1/genetics
Czasopismo naukowe
Tytuł:
Impact of minimal solid and micropapillary components on invasive lung adenocarcinoma recurrence.
Autorzy:
Chen C; Department of Cardio-Thoracic Surgery, Zhoushan Hospital, 739 Dingshen Road, Zhoushan, Zhejiang 316000, PR China.
Chen ZJ; Department of Cardio-Thoracic Surgery, Zhoushan Hospital, 739 Dingshen Road, Zhoushan, Zhejiang 316000, PR China.
Li WJ; Department of Cardio-Thoracic Surgery, Zhoushan Hospital, 739 Dingshen Road, Zhoushan, Zhejiang 316000, PR China.
Pan XF; Department of Cardio-Thoracic Surgery, Zhoushan Hospital, 739 Dingshen Road, Zhoushan, Zhejiang 316000, PR China.
Wen YY; Department of Pathology, Zhoushan Hospital, 739 Dingshen Road, Zhoushan, Zhejiang 316000, PR China.
Deng T; Department of Pathology, Zhoushan Hospital, 739 Dingshen Road, Zhoushan, Zhejiang 316000, PR China.
Le HB; Department of Cardio-Thoracic Surgery, Zhoushan Hospital, 739 Dingshen Road, Zhoushan, Zhejiang 316000, PR China.
Zhang YK; Department of Cardio-Thoracic Surgery, Zhoushan Hospital, 739 Dingshen Road, Zhoushan, Zhejiang 316000, PR China.
Zhang BJ; Department of Cardio-Thoracic Surgery, Zhoushan Hospital, 739 Dingshen Road, Zhoushan, Zhejiang 316000, PR China. Electronic address: .
Pokaż więcej
Źródło:
Annals of diagnostic pathology [Ann Diagn Pathol] 2022 Aug; Vol. 59, pp. 151945. Date of Electronic Publication: 2022 Apr 01.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*
Lung Neoplasms*/pathology
Humans ; Neoplasm Recurrence, Local/pathology ; Neoplasm Staging ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł:
A triple-classification for the evaluation of lung nodules manifesting as pure ground-glass sign: a CT-based radiomic analysis.
Autorzy:
Yu Z; Department of Radiology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, People's Republic of China.; School of Medicine, Xiamen University, Xiamen, Fujian Province, China.
Xu C; School of Medicine, Xiamen University, Xiamen, Fujian Province, China.
Zhang Y; Department of Radiology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, People's Republic of China.
Ji F; Department of Radiology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, People's Republic of China. .
Pokaż więcej
Źródło:
BMC medical imaging [BMC Med Imaging] 2022 Jul 27; Vol. 22 (1), pp. 133. Date of Electronic Publication: 2022 Jul 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Adenocarcinoma*/pathology
Adenocarcinoma in Situ*/pathology
Adenocarcinoma in Situ*/surgery
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/pathology
Humans ; Hyperplasia/pathology ; Lung/pathology ; Neoplasm Invasiveness/pathology ; Retrospective Studies ; Tomography, X-Ray Computed/methods
Czasopismo naukowe
Tytuł:
Associations of IFT20 and GM130 protein expressions with clinicopathological features and survival of patients with lung adenocarcinoma.
Autorzy:
Li L; Department of Occupational and Environmental Health, School of Public Health, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China.; Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China.
Chen Y; Institute of Pathology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, Hubei, China.
Liao W; Department of Respiratory and Critical Care Medicine, Fifth Hospital in Wuhan, Wuhan, 430050, Hubei, China.
Yu Q; Department of Occupational and Environmental Health, School of Public Health, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China.; Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China.
Lin H; Department of Occupational and Environmental Health, School of Public Health, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China.; Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China.
Shi Y; Department of Occupational and Environmental Health, School of Public Health, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China.; Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China.
Zhang L; Department of Occupational and Environmental Health, School of Public Health, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China.; Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China.
Fu G; Department of Occupational and Environmental Health, School of Public Health, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China.; Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China.
Wang Z; Department of Basic Medicine, Medical College, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China.
Li X; Department of Basic Medicine, Medical College, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China.
Kong X; Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, Hubei, China.
Zhou T; Department of Occupational and Environmental Health, School of Public Health, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China. .; Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Wuhan University of Science and Technology, Wuhan, 430065, Hubei, China. .
Qin L; Institute of Pathology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, Hubei, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2022 Jul 22; Vol. 22 (1), pp. 809. Date of Electronic Publication: 2022 Jul 22.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*/pathology
Lung Neoplasms*/pathology
Autoantigens/*metabolism
Membrane Proteins/*metabolism
Biomarkers, Tumor/metabolism ; Carrier Proteins ; Humans ; Lymphatic Metastasis ; Neoplasm Staging ; Prognosis
Czasopismo naukowe
Tytuł:
Serum tumor markers level and their predictive values for solid and micropapillary components in lung adenocarcinoma.
Autorzy:
Li Z; Department of Thoracic Surgery, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Wu W; Department of Thoracic Surgery, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Pan X; Department of Thoracic Surgery, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Li F; Department of Thoracic Surgery, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Zhu Q; Department of Thoracic Surgery, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
He Z; Department of Thoracic Surgery, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Chen L; Department of Thoracic Surgery, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2022 Jul; Vol. 11 (14), pp. 2855-2864. Date of Electronic Publication: 2022 Mar 14.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*
Lung Neoplasms*/pathology
Antigens, Neoplasm ; Biomarkers, Tumor ; Carcinoembryonic Antigen ; Humans ; Keratin-19 ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Cervical adenocarcinoma in situ during pregnancy and subsequent fertility-sparing therapy challenge.
Autorzy:
Sánchez-Cuerda C; Department of Obstetrics and Gynecology, Infanta Sofía University Hospital, San Sebastián de los Reyes, Madrid, Spain.
Cuadra M; Department of Obstetrics and Gynecology, Infanta Sofía University Hospital, San Sebastián de los Reyes, Madrid, Spain.
Gámir S; Department of Obstetrics and Gynecology, Infanta Sofía University Hospital, San Sebastián de los Reyes, Madrid, Spain.; European University Madrid, Madrid, Spain.
Lobo P; Department of Obstetrics and Gynecology, Infanta Sofía University Hospital, San Sebastián de los Reyes, Madrid, Spain.; European University Madrid, Madrid, Spain.
Elices M; Department of Pathology, Infanta Sofía University Hospital, San Sebastián de los Reyes, Madrid, Spain.; European University Madrid, Madrid, Spain.
Cabrera Y; Department of Obstetrics and Gynecology, Infanta Sofía University Hospital, San Sebastián de los Reyes, Madrid, Spain.; European University Madrid, Madrid, Spain.
Pokaż więcej
Źródło:
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics [Int J Gynaecol Obstet] 2022 Jul; Vol. 158 (1), pp. 21-26. Date of Electronic Publication: 2021 Oct 23.
Typ publikacji:
Case Reports; Journal Article; Review
MeSH Terms:
Adenocarcinoma*/diagnosis
Adenocarcinoma*/surgery
Adenocarcinoma in Situ*/surgery
Cervical Intraepithelial Neoplasia*/diagnosis
Uterine Cervical Neoplasms*/diagnosis
Uterine Cervical Neoplasms*/surgery
Adult ; Conization/methods ; Female ; Humans ; Pregnancy ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Comprehensive analysis of CXCR family members in lung adenocarcinoma with prognostic values.
Autorzy:
Hu LT; Basic Medical College, Jiamusi University, Jiamusi, 154002, Heilongjiang, China.; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China.
Deng WJ; Basic Medical College, Jiamusi University, Jiamusi, 154002, Heilongjiang, China.; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China.
Chu ZS; Basic Medical College, Jiamusi University, Jiamusi, 154002, Heilongjiang, China.; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China.
Sun L; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China.; First Affiliated Hospital, Jiamusi University, Jiamusi, 154002, Heilongjiang, China.
Zhang CB; Department of Medical Technology, Collaborative Innovation Center for Translation Medical Testing and Application Technology Zhangzhou, Zhang Zhou Health Vocational College, Zhangzhou, 363000, Fujian Province, China.
Lu SZ; Basic Medical College, Jiamusi University, Jiamusi, 154002, Heilongjiang, China.; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China.
Weng JR; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China.; Stomatological Hospital, Jiamusi University, Jiamusi, 154002, Heilongjiang, China.
Ren QS; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China.; Stomatological Hospital, Jiamusi University, Jiamusi, 154002, Heilongjiang, China.
Dong XY; Basic Medical College, Jiamusi University, Jiamusi, 154002, Heilongjiang, China.; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China.
Li WD; Basic Medical College, Jiamusi University, Jiamusi, 154002, Heilongjiang, China.; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China.
Li XB; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China.; First Affiliated Hospital, Jiamusi University, Jiamusi, 154002, Heilongjiang, China.
Du YT; Department of Laboratory, Cancer Hospital of China Medical University, Shenyang,, Liaoning Province, China.
Li Y; Basic Medical College, Jiamusi University, Jiamusi, 154002, Heilongjiang, China. .; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China. .
Wang WQ; Basic Medical College, Jiamusi University, Jiamusi, 154002, Heilongjiang, China. .; Key Laboratory of Microecology-Immune Regulatory Network and Related Diseases, Jiamusi, 154002, Heilongjiang, China. .
Pokaż więcej
Źródło:
BMC pulmonary medicine [BMC Pulm Med] 2022 Jun 29; Vol. 22 (1), pp. 259. Date of Electronic Publication: 2022 Jun 29.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/pathology
Lung Neoplasms*/pathology
Humans ; Prognosis ; RNA, Messenger/genetics ; RNA, Messenger/metabolism
Czasopismo naukowe
Tytuł:
E2F2 promotes lung adenocarcinoma progression through B-Myb- and FOXM1-facilitated core transcription regulatory circuitry.
Autorzy:
Du K; Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.; Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China.
Sun S; Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.; Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China.
Jiang T; Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.; Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China.
Liu T; Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.; Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China.
Zuo X; Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.; Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China.
Xia X; Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.; Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China.
Liu X; Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.; Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China.
Wang Y; Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.; Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China.
Bu Y; Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.; Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, China.
Pokaż więcej
Źródło:
International journal of biological sciences [Int J Biol Sci] 2022 Jun 25; Vol. 18 (10), pp. 4151-4170. Date of Electronic Publication: 2022 Jun 25 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*/genetics
Adenocarcinoma of Lung*/metabolism
Lung Neoplasms*/metabolism
E2F2 Transcription Factor/*metabolism
Animals ; Gene Expression Regulation ; Gene Expression Regulation, Neoplastic/genetics ; Mice ; Transcription Factors/metabolism
Czasopismo naukowe
Tytuł:
Predictors of Invasiveness in Adenocarcinoma of Lung with Lepidic Growth Pattern.
Autorzy:
Young TJ; Division of Pulmonary and Critical Care, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Salehi-Rad R; Division of Pulmonary and Critical Care, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Ronaghi R; Division of Pulmonary and Critical Care, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Yanagawa J; Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Shahrouki P; Department of Radiology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Villegas BE; Department of Radiology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Cone B; Department of Pathology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Fishbein GA; Department of Pathology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Wallace WD; Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Abtin F; Department of Radiology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Barjaktarevic I; Division of Pulmonary and Critical Care, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Pokaż więcej
Źródło:
Medical sciences (Basel, Switzerland) [Med Sci (Basel)] 2022 Jun 22; Vol. 10 (3). Date of Electronic Publication: 2022 Jun 22.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*/diagnostic imaging
Adenocarcinoma*/pathology
Adenocarcinoma in Situ*/pathology
Adenocarcinoma of Lung*/diagnostic imaging
Adenocarcinoma of Lung*/pathology
Lung Neoplasms*/pathology
Lung Neoplasms*/surgery
Humans ; Lung/diagnostic imaging ; Lung/pathology ; Neoplasm Invasiveness/pathology ; Neoplasm Staging
Czasopismo naukowe
Tytuł:
Native T1 mapping for differentiating the histopathologic type, grade, and stage of rectal adenocarcinoma: a pilot study.
Autorzy:
Li J; Department of MRI, the First Affiliated Hospital of Zhengzhou University, No.1, Jianshe Dong Road, Zhengzhou, 450052, China.
Gao X; Department of MRI, the First Affiliated Hospital of Zhengzhou University, No.1, Jianshe Dong Road, Zhengzhou, 450052, China.
Dominik Nickel M; Siemens Healthcare GmbH, 91052, Erlangen, Germany.
Cheng J; Department of MRI, the First Affiliated Hospital of Zhengzhou University, No.1, Jianshe Dong Road, Zhengzhou, 450052, China. .
Zhu J; MR Collaboration, Siemens Healthcare Ltd, Beijing, 100000, China.
Pokaż więcej
Źródło:
Cancer imaging : the official publication of the International Cancer Imaging Society [Cancer Imaging] 2022 Jun 17; Vol. 22 (1), pp. 30. Date of Electronic Publication: 2022 Jun 17.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*/diagnostic imaging
Adenocarcinoma*/pathology
Adenocarcinoma, Mucinous*/diagnostic imaging
Rectal Neoplasms*/diagnostic imaging
Rectal Neoplasms*/pathology
Diffusion Magnetic Resonance Imaging/methods ; Humans ; Pilot Projects ; ROC Curve ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Comprehensive Analysis and Reinforcement Learning of Hypoxic Genes Based on Four Machine Learning Algorithms for Estimating the Immune Landscape, Clinical Outcomes, and Therapeutic Implications in Patients With Lung Adenocarcinoma.
Autorzy:
Sun Z; Department of Laboratory Medicine, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zeng Y; Department of Thyroid and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
Yuan T; Department of Laboratory Medicine, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Chen X; Department of Laboratory Medicine, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wang H; Department of Laboratory Medicine, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Ma X; Department of Laboratory Medicine, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Institute of Molecular Medicine, Department of Laboratory Medicine, Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, State Key Laboratory of Oncogene and Related Genes, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2022 Jun 10; Vol. 13, pp. 906889. Date of Electronic Publication: 2022 Jun 10 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*/pathology
Lung Neoplasms*/pathology
Algorithms ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Humans ; Hypoxia/genetics ; Machine Learning
Czasopismo naukowe
Tytuł:
Junctional adhesion molecule-like protein promotes tumor progression via the Wnt/β-catenin signaling pathway in lung adenocarcinoma.
Autorzy:
Wu Q; Department of Pulmonary and Critical Care Medicine, Shandong Key Laboratory of Infectious Respiratory Diseases, Qilu Hospital of Shandong University, Jinan, 250012, China.; Department of Pulmonary and Critical Care Medicine, The Second Hospital of Shandong University, Jinan, 250033, China.
Li R; Department of Pulmonary and Critical Care Medicine, Shandong Key Laboratory of Infectious Respiratory Diseases, Qilu Hospital of Shandong University, Jinan, 250012, China.
Wang QX; Department of Pulmonary and Critical Care Medicine, Shandong Key Laboratory of Infectious Respiratory Diseases, Qilu Hospital of Shandong University, Jinan, 250012, China.
Zhang MY; Department of Pulmonary and Critical Care Medicine, Shandong Key Laboratory of Infectious Respiratory Diseases, Qilu Hospital of Shandong University, Jinan, 250012, China.
Liu TT; Department of Pulmonary and Critical Care Medicine, Shandong Key Laboratory of Infectious Respiratory Diseases, Qilu Hospital of Shandong University, Jinan, 250012, China.
Qu YQ; Department of Pulmonary and Critical Care Medicine, Shandong Key Laboratory of Infectious Respiratory Diseases, Qilu Hospital of Shandong University, Jinan, 250012, China. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2022 Jun 07; Vol. 20 (1), pp. 260. Date of Electronic Publication: 2022 Jun 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Adenocarcinoma*/genetics
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/pathology
Lung Neoplasms*/pathology
Cell Adhesion Molecules/*metabolism
Cell Line, Tumor ; Cell Movement/genetics ; Cell Proliferation/genetics ; Gene Expression Regulation, Neoplastic ; Humans ; Junctional Adhesion Molecules/genetics ; Junctional Adhesion Molecules/metabolism ; Wnt Signaling Pathway ; beta Catenin/metabolism
Czasopismo naukowe
Tytuł:
Pralsetinib treatment for multiple RET fusions in lung adenocarcinoma: a case report.
Autorzy:
Cao X; Department of Oncology, The Affiliated Jiangyin Hospital of Southeast University Medical College, Wuxi, China.
Liu X; Department of Oncology, The Affiliated Jiangyin Hospital of Southeast University Medical College, Wuxi, China.
Wang S; Department of Oncology, The Affiliated Jiangyin Hospital of Southeast University Medical College, Wuxi, China.
Liu Z; Department of Oncology, The Affiliated Jiangyin Hospital of Southeast University Medical College, Wuxi, China.
Ren X; Department of Oncology, The Affiliated Jiangyin Hospital of Southeast University Medical College, Wuxi, China.
Sun D; Institute of Biomedical Research, Genecast Biotechnology Co., Ltd, Wuxi, China.
Deng L; Department of Oncology, The Affiliated Jiangyin Hospital of Southeast University Medical College, Wuxi, China.
Pokaż więcej
Źródło:
The Journal of international medical research [J Int Med Res] 2022 Jun; Vol. 50 (6), pp. 3000605221105368.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Adenocarcinoma*/drug therapy
Adenocarcinoma*/genetics
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Humans ; Male ; Protein Kinase Inhibitors/therapeutic use ; Proto-Oncogene Proteins c-ret/genetics ; Proto-Oncogene Proteins c-ret/therapeutic use ; Pyrazoles ; Pyridines ; Pyrimidines
Czasopismo naukowe
Tytuł:
Use of a highly sensitive lung cancer compact panel to detect KRAS G12D in the wash fluid from a lung tumor: A case report.
Autorzy:
Minami D; Department of Respiratory Medicine, Himeji Saint Mary's Hospital, Himeji, Japan.; Department of Respiratory Medicine, Hosoya Hospital, Ibara, Japan.
Takigawa N; Department of Internal Medicine, Himeji Saint Mary's Hospital, Himeji, Japan.; Department of Internal Medicine 4, Kawasaki Medical School, Okayama, Japan.
Nakajima Y; Department of Respiratory Medicine, Himeji Saint Mary's Hospital, Himeji, Japan.
Miyahara N; Department of Internal Medicine, Himeji Saint Mary's Hospital, Himeji, Japan.
Mizumori Y; Department of Respiratory Medicine, National Hospital Organization Himeji Medical Center, Himeji, Japan.
Ueda M; Department of Thoracic Surgery, National Hospital Organization Himeji Medical Center, Japan.
Nakamura S; DNA Chip Research Inc, Japan.
Suzuki F; DNA Chip Research Inc, Japan.
Sato Y; DNA Chip Research Inc, Japan.
Morikawa K; Division of Respiratory Medicine, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
Kanehiro A; Department of Internal Medicine, Himeji Saint Mary's Hospital, Himeji, Japan.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2022 Jun; Vol. 13 (11), pp. 1735-1738. Date of Electronic Publication: 2022 May 12.
Typ publikacji:
Case Reports
MeSH Terms:
Adenocarcinoma of Lung*/genetics
Adenocarcinoma, Mucinous*/diagnosis
Adenocarcinoma, Mucinous*/genetics
Adenocarcinoma, Mucinous*/surgery
Lung Neoplasms*/diagnosis
Lung Neoplasms*/genetics
Lung Neoplasms*/surgery
Aged ; Bronchoscopy/methods ; Female ; Humans ; Image-Guided Biopsy/methods ; Proto-Oncogene Proteins p21(ras)/genetics
Raport
Tytuł:
Clinical relevance of PD-L2 expression in surgically resected lung adenocarcinoma.
Autorzy:
Takamochi K; Department of General Thoracic Surgery, Juntendo University School of Medicine, Tokyo, Japan. Electronic address: .
Hara K; Department of Human Pathology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Hayashi T; Department of Human Pathology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Kohsaka S; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan.
Takahashi F; Department of Respiratory Medicine, Juntendo University School of Medicine, Tokyo, Japan.
Suehara Y; Department of Orthopedic Surgery, Juntendo University School of Medicine, Tokyo, Japan.
Shimokawa M; Department of Biostatistics, Yamaguchi University Graduate School of Medicine, Ube, Japan.
Suzuki K; Department of General Thoracic Surgery, Juntendo University School of Medicine, Tokyo, Japan.
Pokaż więcej
Źródło:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2022 Jun; Vol. 168, pp. 50-58. Date of Electronic Publication: 2022 Apr 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Adenocarcinoma*/genetics
Adenocarcinoma*/metabolism
Adenocarcinoma*/surgery
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/surgery
Lung Neoplasms*/genetics
Lung Neoplasms*/metabolism
Lung Neoplasms*/surgery
Programmed Cell Death 1 Ligand 2 Protein/*metabolism
B7-H1 Antigen/genetics ; B7-H1 Antigen/metabolism ; Biomarkers, Tumor/metabolism ; ErbB Receptors/metabolism ; Humans ; Male ; Neoplasm Recurrence, Local ; Programmed Cell Death 1 Receptor/metabolism ; Protein-Tyrosine Kinases/genetics ; Proto-Oncogene Proteins/genetics ; Proto-Oncogene Proteins p21(ras)/metabolism ; Receptor Protein-Tyrosine Kinases/genetics
Czasopismo naukowe
Tytuł:
TXNDC9 knockdown inhibits lung adenocarcinoma progression by targeting YWHAG.
Autorzy:
Wang J; Respiratory and Critical Care Medicine Department, The Second People's Hospital of Shaanxi Province, Xi'an, Shaanxi 710005, P.R. China.
Pan X; General Surgery Department, Shaanxi Provincial Cancer Hospital, Xi'an, Shaanxi 710600, P.R. China.
Li J; Radiotherapy Department, Shaanxi Provincial Cancer Hospital, Xi'an, Shaanxi 710600, P.R. China.
Zhao J; Radiotherapy Department, Shaanxi Provincial Cancer Hospital, Xi'an, Shaanxi 710600, P.R. China.
Pokaż więcej
Źródło:
Molecular medicine reports [Mol Med Rep] 2022 Jun; Vol. 25 (6). Date of Electronic Publication: 2022 Apr 29.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*
Adenocarcinoma of Lung*/pathology
Lung Neoplasms*/pathology
Thioredoxins/*metabolism
14-3-3 Proteins/metabolism ; Cell Line, Tumor ; Cell Proliferation/genetics ; Humans
Czasopismo naukowe
Tytuł:
Ureteral metastasis of small cell lung cancer transformed from lung adenocarcinoma: A case report.
Autorzy:
Wang Y; Department of Thoracic Surgery, The First People's Hospital of Neijiang, Neijiang Affiliated Hospital of Chongqing Medical University, Neijiang, China.
Li J; Department of Thoracic Surgery, The First People's Hospital of Neijiang, Neijiang Affiliated Hospital of Chongqing Medical University, Neijiang, China.
Luo L; Department of Thoracic Surgery, The First People's Hospital of Neijiang, Neijiang Affiliated Hospital of Chongqing Medical University, Neijiang, China.
Li X; Department of Thoracic Surgery, The First People's Hospital of Neijiang, Neijiang Affiliated Hospital of Chongqing Medical University, Neijiang, China.
Liu Q; Department of Pathology, The First People's Hospital of Neijiang, Neijiang Affiliated Hospital of Chongqing Medical University, Neijiang, China.
Wang Y; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.
Che G; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.
Xie X; Department of Thoracic Surgery, The First People's Hospital of Neijiang, Neijiang Affiliated Hospital of Chongqing Medical University, Neijiang, China.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2022 Jun; Vol. 13 (11), pp. 1731-1734. Date of Electronic Publication: 2022 Apr 18.
Typ publikacji:
Case Reports
MeSH Terms:
Adenocarcinoma*/drug therapy
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/pathology
Lung Neoplasms*/drug therapy
Lung Neoplasms*/pathology
Small Cell Lung Carcinoma*/drug therapy
Small Cell Lung Carcinoma*/pathology
Female ; Gefitinib/therapeutic use ; Humans ; Middle Aged
Raport

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz